The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Morningside Venture Investments Ltd since year 2005.
The trader's CIK number is 1543112.
At the time of this reporting, Morningside Venture Investments Ltd is the 10% Owner of Apellis Pharmaceuticals, Inc. .
(stock ticker symbol APLS).
See this page for all insider trading activities at Apellis Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-03-11||APLS||Apellis Pharmaceuticals, Inc.||Buy||441,176||17.00||7,499,992|
|2018-09-21||APLS||Apellis Pharmaceuticals, Inc.||Buy||40,000||19.84||793,600|
|2018-09-20||APLS||Apellis Pharmaceuticals, Inc.||Buy||41,323||19.11||789,682|
|2018-09-19||APLS||Apellis Pharmaceuticals, Inc.||Buy||60,000||18.09||1,085,400|
|2018-09-18||APLS||Apellis Pharmaceuticals, Inc.||Buy||40,000||18.47||738,800|
|2018-09-17||APLS||Apellis Pharmaceuticals, Inc.||Buy||40,000||18.67||746,800|
|2018-06-25||KZR||Kezar Life Sciences, Inc.||Buy||250,000||15.00||3,750,000|
|2017-11-13||APLS||Apellis Pharmaceuticals, Inc.||Buy||575,000||14.00||8,050,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Morningside Venture Investments Ltd (10% Owner of Apellis Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.